Cited by 171Pancreatic function and diabetesDiabetes and associated disordersDiabetes Management and Research

The journey of islet cell transplantation and future development

Open access
Gamble, Anissa, Pepper, Andrew R., Bruni, Antonio, Shapiro, A. M. James·2018·Islets

Abstract

Intraportal islet transplantation has proven to be efficacious in preventing severe hypoglycemia and restoring insulin independence in selected patients with type 1 diabetes. Multiple islet infusions are often required to achieve and maintain insulin independence. Many challenges remain in clinical islet transplantation, including substantial islet cell loss early and late after islet infusion. Contributions to graft loss include the instant blood-mediated inflammatory reaction, potent host auto- and alloimmune responses, and beta cell toxicity from immunosuppressive agents. Protective strategies are being tested to circumvent several of these events including exploration of alternative transplantation sites, stem cell-derived insulin producing cell therapies, co-transplantation with mesenchymal stem cells or exploration of novel immune protective agents. Herein, we provide a brief introduction and history of islet cell transplantation, limitations associated with this procedure and methods to alleviate islet cell loss as a means to improve engraftment outcomes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/19382014.2018.1428511

Cites

131 of 131 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 133 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

  1. Williams P. Notes on diabetes treated with extract and by grafts of sheep's pancreas. Br Med J. 1894; 2:1303-4.
  2. Gala-Lopez B. L. PAR, Dinyari P., Malcolm A. J., Kin T., Pawlick L. R., Senior P. A., Shapiro A.M. J. Subcutaneous clinical islet transplantation in a prevascularized subcutane- ous pouch -preliminary experience. CellR4. 2016; 4:e2132.
  3. L. G-LB. The metalloporphyrin BMX-010 in human islet iso- lation and clinical transplantation. CellR4. 2016; 4:2066.

Cited by

Sorted by citations

Authors
Gamble, A., Pepper, A. R., Bruni, A., & Shapiro, A. M. J.
Affiliations
  • University of Alberta (CA)
  • Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada
Corresponding author
Shapiro, A. M. James
Venue
Islets
Published
2018-02-05
Volume
10
Issue
2
Pages
80-94
ISSN
  • 1938-2014 (ISSN-L)
  • 1938-2022
OpenAlex
W2791423015
Cited by
171
References
133
Citations by year
2026: 7 · 2025: 16 · 2024: 14 · 2023: 29 · 2022: 30 · 2021: 32 · 2020: 32 · 2019: 9 · 2018: 2
FWCI
4.17
Type
journal article
Language
en
Open access
Locations
  • Islets (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Diabetes Research Institute Foundation
  • Stem Cell Network
  • Alberta Innovates
  • National Institutes of Health
  • Canadian Institutes of Health Research
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
islet transplantation, type 1 diabetes, graft loss, islet engraftment, hypoglycemia prevention, insulin independence, islet autoimmunity, immunosuppressants, beta-cell toxicity, intraportal transplantation, mesenchymal stem cells, immunoprotection
MeSH terms
Animals, Diabetes Mellitus, Type 1, Graft Survival, Humans, Islets of Langerhans, Autoimmunity, Islets of Langerhans Transplantation, Neovascularization, Physiologic, Tissue and Organ Harvesting, Pluripotent Stem Cells, Mesenchymal Stem Cell Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review